Cargando…

Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers

The prognostic indicators for synchronous multiple primary non-small cell lung cancer (NSCLC) vary across reports. In present study, the prognostic factors for the patients with synchronous multiple primary NSCLC were analyzed in a large cohort. A total of 285 patients with synchronous multiple prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhirong, Gao, Shugeng, Mao, Yousheng, Mu, Juwei, Xue, Qi, Feng, Xiaoli, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890551/
https://www.ncbi.nlm.nih.gov/pubmed/27254665
http://dx.doi.org/10.1038/srep23252
_version_ 1782435125561131008
author Zhang, Zhirong
Gao, Shugeng
Mao, Yousheng
Mu, Juwei
Xue, Qi
Feng, Xiaoli
He, Jie
author_facet Zhang, Zhirong
Gao, Shugeng
Mao, Yousheng
Mu, Juwei
Xue, Qi
Feng, Xiaoli
He, Jie
author_sort Zhang, Zhirong
collection PubMed
description The prognostic indicators for synchronous multiple primary non-small cell lung cancer (NSCLC) vary across reports. In present study, the prognostic factors for the patients with synchronous multiple primary NSCLC were analyzed in a large cohort. A total of 285 patients with synchronous multiple primary NSCLC who underwent radical surgical resection and with complete follow-up information were included in this study. The Kaplan-Meier method were used for survival analysis, Cox proportional hazards regression models were used for risk factors evaluation. Among them, 94 (33.0%) patients had bilateral tumors and 51 (17.9%) had multiple (≥3) tumors. The 5-year disease-free survival (DFS) and overall survival (OS) rate was 58.7% and 77.6%, respectively. Univariate analysis identified parameters conferring shorter OS including male gender, symptomatic disease, negative family history, large maximal tumor size, not all adenocarcinomas, advanced highest T stage, and lymph node involvement. Multivariate analysis showed that male gender (p = 0.020), symptomatic disease (p = 0.017), and lymph node involvement (p < 0.001) were independent adverse prognosticators. For patients with multiple adenocarcinomas, the 5-year DFS and OS rate was 59.6% and 82.4%, respectively. The subtypes other than lepidic predominant (p < 0.001) and lymph node involvement (p = 0.002) were the independent unfavorable prognosticators. In conclusion, we identified independent prognosticators which will provide the valuable clues for postoperative management of patients with synchronous multiple primary NSCLC.
format Online
Article
Text
id pubmed-4890551
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48905512016-06-09 Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers Zhang, Zhirong Gao, Shugeng Mao, Yousheng Mu, Juwei Xue, Qi Feng, Xiaoli He, Jie Sci Rep Article The prognostic indicators for synchronous multiple primary non-small cell lung cancer (NSCLC) vary across reports. In present study, the prognostic factors for the patients with synchronous multiple primary NSCLC were analyzed in a large cohort. A total of 285 patients with synchronous multiple primary NSCLC who underwent radical surgical resection and with complete follow-up information were included in this study. The Kaplan-Meier method were used for survival analysis, Cox proportional hazards regression models were used for risk factors evaluation. Among them, 94 (33.0%) patients had bilateral tumors and 51 (17.9%) had multiple (≥3) tumors. The 5-year disease-free survival (DFS) and overall survival (OS) rate was 58.7% and 77.6%, respectively. Univariate analysis identified parameters conferring shorter OS including male gender, symptomatic disease, negative family history, large maximal tumor size, not all adenocarcinomas, advanced highest T stage, and lymph node involvement. Multivariate analysis showed that male gender (p = 0.020), symptomatic disease (p = 0.017), and lymph node involvement (p < 0.001) were independent adverse prognosticators. For patients with multiple adenocarcinomas, the 5-year DFS and OS rate was 59.6% and 82.4%, respectively. The subtypes other than lepidic predominant (p < 0.001) and lymph node involvement (p = 0.002) were the independent unfavorable prognosticators. In conclusion, we identified independent prognosticators which will provide the valuable clues for postoperative management of patients with synchronous multiple primary NSCLC. Nature Publishing Group 2016-06-02 /pmc/articles/PMC4890551/ /pubmed/27254665 http://dx.doi.org/10.1038/srep23252 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Zhang, Zhirong
Gao, Shugeng
Mao, Yousheng
Mu, Juwei
Xue, Qi
Feng, Xiaoli
He, Jie
Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
title Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
title_full Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
title_fullStr Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
title_full_unstemmed Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
title_short Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
title_sort surgical outcomes of synchronous multiple primary non-small cell lung cancers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890551/
https://www.ncbi.nlm.nih.gov/pubmed/27254665
http://dx.doi.org/10.1038/srep23252
work_keys_str_mv AT zhangzhirong surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers
AT gaoshugeng surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers
AT maoyousheng surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers
AT mujuwei surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers
AT xueqi surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers
AT fengxiaoli surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers
AT hejie surgicaloutcomesofsynchronousmultipleprimarynonsmallcelllungcancers